I-FDA ivume i-belumosudil ekwelashweni kwesifo esingelapheki se-graft-versus-host

Yabelana ngalokhu okuthunyelwe

Agasti 2021: Ngemuva kokwehluleka okungenani kwemigqa emibili yokwelashwa kwesistimu, Ukuphathwa Kwezokudla Nezidakamizwa kugunyaziwe i-belumosudil (Rezurock, Kadmon Pharmaceuticals, LLC), i-kinase inhibitor, yeziguli zabantu abadala nezengane ezineminyaka engu-12 nangaphezulu ezinesifo esingapheli se-graft-versus-host (i-chronic GVHD).

I-KD025-213 (NCT03640481), ukuhlolwa okungahleliwe, kwelebuli evulekile, okuhlolwa okulingene umthamo lapho iziguli ezingama-65 ezine-GVHD engalapheki zelashwa nge-belumosudil 200 mg elawulwa ngomlomo kanye ngosuku, isetshenziselwe ukuhlola ukusebenza kahle.

Izinga lokuphendula eliphelele (ORR) nge-Cycle 7 Day 1 kwakuyisilinganiso sokuphela sokusebenza ngempumelelo, nempendulo iyonke echazwa njengempendulo egcwele (CR) noma impendulo eyingxenye (PR) ngokusho kwe-2014 NIH Consensus Development Project on Clinical Trials in Chronic Graft. -versus-Host Disease imihlahlandlela. I-ORR yayingu-75% (amaphesenti angu-95 CI: 63, 85); I-6% yeziguli ibe nempendulo ephelele, kanti amaphesenti angu-69 abe nempendulo eyingxenye. Isikhathi esivamile esisithathile ukuze uthole impendulo yokuqala kwakuyizinyanga ezingu-1.8 (amaphesenti angu-95 CI: 1.0, 1.9). Ubude besikhathi esimaphakathi sokuphendula kwe-GVHD engapheli kwakuyizinyanga ezingu-1.9, zikalwa kusukela ekuphenduleni kokuqala ngokuqhubeka, ukufa, noma ukwelashwa okusha kwesistimu (amaphesenti angu-95 CI: 1.2, 2.9). Akukho ukufa noma ukuqaliswa kwemithi emisha yesistimu okwenzeka kumaphesenti angu-62 (amaphesenti angu-95 CI: 46, 74) eziguli ezithole impendulo okungenani izinyanga ezingu-12 ngemva kokuphendula.

Ukutheleleka, i-asthenia, isicanucanu, isifo sohudo, i-dyspnea, ukukhwehlela, i-edoema, ukuphuma kwegazi, ubuhlungu besisu, ubuhlungu besisu, ikhanda, i-phosphate yehlile, i-gamma glutamyl transferase yanda, ama-lymphocyte ancipha, futhi umfutho wegazi ophakeme kwakuyizinto ezivame kakhulu ukuphazamiseka (i-20%), kufaka phakathi i-laboratory ukungajwayelekile.

I-Belumosudil kufanele ithathwe kanye ngosuku, ngokudla, ngomthamo wama-200 mg.

Thatha umbono wesibili ngokufakelwa komnkantsha wethambo


Thumela Imininingwane

Bhalisa ku-Newsletter yethu

Thola izibuyekezo futhi ungalokothi uphuthelwe ibhulogi evela kuCancerfax

Okuningi Okuzohlolwa

I-CAR T Cell Therapy Esekelwe Kubantu: Ukuphumelela Nezinselele
Ukwelashwa kwe-CAR T-Cell

I-CAR T Cell Therapy Esekelwe Kubantu: Ukuphumelela kanye Nezinselele

Ukwelashwa kwe-CAR T-cell okusekelwe kumuntu kuguqula ukwelashwa komdlavuza ngokushintsha izakhi zofuzo amaseli omzimba esiguli ukuze aqondise futhi abhubhise amaseli omdlavuza. Ngokusebenzisa amandla esimiso somzimba sokuzivikela ezifweni, lezi zindlela zokwelapha zinikeza ukwelashwa okunamandla futhi okuqondene nomuntu okungahle kube nokuxolelwa okuhlala isikhathi eside ezinhlotsheni ezihlukahlukene zomdlavuza.

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa
Ukwelashwa kwe-CAR T-Cell

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa

I-Cytokine Release Syndrome (CRS) iwukusabela kwamasosha omzimba okuvame ukubangelwa izindlela zokwelapha ezithile ezifana ne-immunotherapy noma i-CAR-T cell therapy. Kuhilela ukukhululwa ngokweqile kwama-cytokines, okubangela izimpawu ezisukela kumkhuhlane nokukhathala kuya ezinkingeni ezingase zibeke ukuphila engozini njengokulimala kwesitho. Ukuphatha kudinga ukuqapha ngokucophelela kanye namasu okungenelela.

Dinga usizo? Ithimba lethu likulungele ukukusiza.

Sifisela ukululama okusheshayo kothandekayo wakho futhi oseduze.

Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton